A COMPARISON BETWEEN CONVALESCENT SERUM AND NON-CONVALESCENT SERUM IN POLIOMYELITIS

Area of Science:

• Immunology
• Epidemiology
• Virology

Background:

• Poliomyelitis serum therapy was a key treatment modality.
• Understanding neutralizing antibody levels in the general population is crucial for assessing treatment efficacy and public health strategies.

Purpose of the Study:

• To assess the neutralizing antibody potency in sera from apparently healthy urban adults.
• To investigate the relationship between contact history (known contacts vs. non-contacts) and serum neutralizing power.
• To compare the efficacy of normal serum versus convalescent serum in treating early poliomyelitis.

Main Methods:

• Sera from 29 urban adults were tested for neutralizing antibody levels against poliovirus.
• Participants were categorized based on their contact history with poliomyelitis cases.
• Two clinical series of early poliomyelitis cases were treated, one with normal serum and the other with convalescent serum.

Main Results:

• A wide range of neutralizing antibody potencies was observed in the adult population.
• Higher antibody levels were more prevalent in individuals with known contact history.
• Pooled sera from known contacts showed slightly higher neutralizing strength than non-contacts.
• No significant difference in treatment outcomes was observed between patients receiving normal serum and those receiving convalescent serum.

Conclusions:

• Individual variations in poliovirus neutralizing antibodies exist within the urban adult population.
• Contact with poliomyelitis cases may correlate with increased neutralizing antibody levels.
• Current evidence does not support a differential benefit of convalescent serum over normal serum in early poliomyelitis treatment.